Company patents

RECURSION PHARMACEUTICALS, INC.

RECURSION PHARMACEUTICALS, INC. exhibits a clear, albeit volatile, focus on Bioinformatics, which constitutes 40.0% of its portfolio and saw a remarkable +375.0% growth in 2025, despite a -52.6% decline so far in 2026. Surprisingly, while heavily invested in computing categories like Machine Learning & AI (13.8%) and Computer Vision (13.8%), the company has also rapidly emerged in the core pharmaceutical area of Heterocyclic Compounds (Pharma), with 8 patents in 2026 after a -100.0% decline in 2025, suggesting a renewed emphasis on fundamental drug discovery alongside its AI-driven approach.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

80 US filings (since 2023) · 12 categories · 14 themes

Computational Biology & Drug Discovery Design

Applying computational methods, often involving machine learning and multiomics data, to design, analyze, and understand biomolecules, genetic sequences, or complex biological systems.

Bioinformatics
Who else files here? →
43since 2023
+250.0%YoY
Clinical Diagnostics & Prognostics

Computational methods and systems for analyzing biological data (e.g., genomic, proteomic, clinical) to diagnose diseases, predict patient prognosis, assess treatment response, or stratify patients for therapy.

Bioinformatics
Who else files here? →
19since 2023
+1100.0%YoY
Multi-omics Data Integration

Methods and systems for combining and analyzing diverse biological datasets (e.g., genomics, transcriptomics, proteomics, metabolomics) to uncover complex biological relationships, disease mechanisms, or temporal trajectories.

Bioinformatics
Who else files here? →
18since 2023
+250.0%YoY
Targeted Small Molecule Therapeutics

Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.

Heterocyclic Compounds (Pharma)Pharmaceutical Preparations
Who else files here? →
11since 2023
+433.3%YoY
Targeted Protein Degradation

Development of small molecules, often bifunctional (e.g., PROTACs) or molecular glues, that induce the ubiquitin-proteasome system or autophagy to selectively degrade specific disease-causing proteins.

Heterocyclic Compounds (Pharma)
Who else files here? →
8since 2023
+233.3%YoY
AI for Medical Diagnostics

Utilizing machine learning, particularly deep learning, to analyze medical data such as images, sensor readings, or physiological signals for disease prediction, diagnosis, or treatment assessment.

BioinformaticsComputer VisionImage ProcessingMachine Learning & AI
Who else files here? →
6since 2023
+50.0%YoY
Generative AI for Images

Techniques utilizing deep learning models like Generative Adversarial Networks (GANs) or diffusion models to create new images, modify existing ones, or generate synthetic data based on various inputs or conditions.

Image ProcessingComputer Vision
Who else files here? →
6since 2023
+50.0%YoY
Chemical Synthesis of Drug Intermediates

Processes and methodologies for the efficient and scalable preparation of complex heterocyclic compounds and their precursors, including specific reaction conditions, purification techniques, and intermediate compounds.

Heterocyclic Compounds (Pharma)
Who else files here? →
5since 2023
+200.0%YoY
Physiological Monitoring & Diagnostics

Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.

Healthcare Informatics
Who else files here? →
4since 2023
new
Nucleic Acid-Based Therapies

Therapeutic strategies employing nucleic acids (DNA, RNA, oligonucleotides) to modulate gene expression, deliver genetic material, or interfere with disease-causing pathways. Includes gene therapy using viral vectors.

Pharmaceutical Preparations
Who else files here? →
2since 2023
+100.0%YoY
Quantum Machine Learning

Developing and applying machine learning algorithms that leverage quantum computing principles, such as quantum circuits or autoencoders, for tasks like simulation or data processing.

Machine Learning & AI
Who else files here? →
1since 2023
new
Federated & Distributed ML

Methods for training machine learning models across multiple decentralized devices or servers while keeping data localized, often involving aggregation of model parameters and secure communication.

Machine Learning & AI
Who else files here? →
1since 2023
new
Multi-modal Sensor Fusion

Techniques for combining data from disparate sensor types (e.g., cameras, radar, mobile device signals) to achieve a more robust and comprehensive understanding of an environment or subject, often leveraging machine learning for interpretation and correlation.

Computer Vision
Who else files here? →
1since 2023
new
Specialized Data Integration

Methods and systems for integrating, transforming, and managing complex or domain-specific data from disparate sources into a unified structure, often for specific applications like social networks, genomics, or business forms.

Databases & Information Retrieval
Who else files here? →
1since 2023
new

Patents

Showing 1-10 of 102

Page 1 of 11